During my career as a senior financial manager I've had experience in the consumer and personal products industries and most recently in the pharmaceutical sector of the healthcare industry. Currently I'm the Chief Financial Officer of an early stage dermatology company seeking investor financing. Over my career I've obtained experience managing company-wide forecasting, budgeting, financial reporting and analysis, SEC reporting, consolidation, and internal control functions. During the ten years as CFO of a speciality pharmaceutical company I raised capital, communicated with sell side analysts, directed the financial due diligence of acquisitions, directed the implementation of the financial module for an ERP system, and participated in Board of Directors' meetings. As a member of the senior management team I guided the financial operations of the company as sales increased from $50M to over $400M. My next position should be in a small to mid-sized consumer product or pharmaceutical company as a CFO where I can utilize my financial management skills to become a contributing member of a senior management team.
Chief Financial Officer
DERMACT PHARMACEUTICAL, Melville, NY2007-Present
Start-up dermatology company focused on developing a topical product to treat pre-cancerous lesions and other skin diseases such as rosacea and psoriasis.
Chief Financial Officer
Participated in road show presentations to venture capitalists, dermatology companies, and private equity firms. Responsible for budgeting, cash forecasting, financial reporting, treasury, risk management, and taxes.
·Collaborated with the CEO preparing presentations and participating in road shows to raise $15M.
·Prepared short and long term budgets in support of the product development strategy totaling $125M.
·Analyzed the size of the markets for the various disease indications.
·Prepared PIPE document for use in an attempted private placement.
·Worked with investment bankers planning the road show for the PIPE.
Jun 1995 - Sep 2006
Chief Financial Officer
PAR PHARMACEUTICAL, Woodcliff Lake, NJ1995 - 2006
$500 million manufacturer and distributor of generic and branded pharmaceutical products with 750 employees.Sales grew 400% to $430 million over a seven year period, peaking at $680 million in 2004.
Vice President and Chief Financial Officer (1996 - 2006)
Responsibility for financial reporting and analysis, budgeting, capital structure, treasury, risk management, accounting, SEC reporting, Sarbanes-Oxley compliance, and taxes. Participated in and presented information on financial matters to the Board of Directors. Principal liaison with the independent auditing firm.
·Raised $200 million in a convertible debt offering to institutional investors to provide funding for acquisitions and product licensing deals.
·Participated in road show for the $350 million private sale of minority shareholder’s 45% ownership position allowing the Company to regain board control.
·Directed financial due diligence for the $140 million acquisition of Kali Laboratories which expanded the product line and internal Research and Development (R&D) capabilities.
·Coordinated the financial aspects of a $20 million equity investment and product distribution deal with Merck KGaA enabling the Company to acquire products and provide funding for R&D projects.
·Negotiated an asset based lending facility of $20 million with GE Capital to fund working capital needs.
·Collaborated with Business Development to cement financial terms and conditions contained in product licensing deals.
·Shared the investor relations function, participating in investment healthcare conferences and earnings conference calls.
·Established agendas and prepared materials with the Chairman of the Audit Committee for meetings.Principal management representative on the Audit Committee.
Nov 1989 - Mar 1994
TAMBRANDS INC., White Plains, NY1989 - 1994
$650 million multinational personal products company with 3,000 employees worldwide
Vice President and Controller
Responsibility for worldwide controller’s function including consolidation, financial reporting, budgeting, financial planning, accounting policies, and SEC filings.Participant, Board of Directors’ Audit Committee.
Principal liaison with the independent auditing firm.
·Directed the implementation of a new internal financial reporting system on an AS400 platform utilizing JD Edwards software to establish accountability and monitor financial benchmarks.
·Reengineered accounting processes to improve efficiency and lower costs.Reduced monthly closing cycle 150%, from 20 to 8 days.
·Implemented a long-range planning tool to assist in the development of a long-term financial and operational strategy including new product introductions and pricing strategies.
·Assisted in the creation of a foreign exchange hedging program to protect internationally derived earnings.Monitored results and exposures on a monthly basis.
·Initiated a monthly volume, sales and earnings forecast to track financial results.
1983 - 1989
RJR NABISCO, INC., New York, NY1983 - 1989
$15 billion multinational manufacturer and distributor of consumer products
Assistant Corporate Controller, Atlanta,GA(1988-1989)
Responsibility for the financial analysis, internal controls, and accounting of the in-house television media buying group with billings of $200 million and the equity investment in ESPN.
Vice President - Finance and Administration – Ohlmeyer Communications Company (1983 – 1988)
Engaged in TV entertainment and sports productions (including Skins Game), sports events management, and media buying activities for this corporate affiliate formed by a joint venture to produce advertising and marketing deliverables in-house.Revenues grew from $3 million to $250 million in five-year period.